For instance, in cystic fibrosis, precision medicine has revolutionized treatment through the identification of genetic mutations like F508del, enabling the development of targeted therapies such as cystic fibrosis transmembrane conductance regulator (CFTR) modulators [239,240,241]. This evidence concerns the gene CFTR and cystic fibrosis.